Slightly tangential to Triple agonist sounds but kevin_tulsa reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
Saving this for reference. Quality thread.
Want to share my personal experience related to Triple agonist sounds scary - since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 269 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 16 months later: I am down 39 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Triple agonist aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsRelevant to Triple agonist sounds scary - — here is my latest bloodwork comparison:
Key improvements: A1C 8.4% → 5.5%, triglycerides 245 → 115 mg/dL, hsCRP 8.0 → 0.9 mg/L. All on tirzepatide for 13 months.
The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.
Want to share my personal experience related to Triple agonist sounds scary - since I think it might help others in a similar situation.
I started my GLP-1 journey in March 2025 at 286 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.
Now, 8 months later: I am down 46 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The Triple agonist aspect specifically was something that made a big difference in my journey.
This forum was my go-to resource throughout.